Gracell Biotechnologies Inc ADR
(GRCL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRCL | AZN | AMGN | GILD | BMY |
| Company | Gracell Biotechnologies Inc ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 10.26 | 200.46 | 365.90 | 144.62 | 60.84 |
| High | 10.28 | 200.46 | 365.90 | 144.62 | 60.84 |
| Low | 10.17 | 200.46 | 365.90 | 144.62 | 60.84 |
| Latest | 10.25 | 200.46 | 365.90 | 144.62 | 60.84 |
| Change | +0.01 | +7.06 | +1.25 | -2.61 | -0.02 |
| % Change | +0.05% | +3.65% | +0.34% | -1.77% | -0.03% |
| Volume | 6,417,100 | 20,447 | 2,158 | 21,283 | 15,118 |
| 20-Day Average Volume | 1,332,340 | 4,504,000 | 3,056,938 | 8,087,009 | 13,103,321 |
| Previous Close | 10.25 | 193.40 | 364.65 | 147.23 | 60.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.21 | 187.94 | 349.59 | 138.42 | 56.74 |
| 20-Day Raw Stochastic | 53.16% | 100.00% | 69.69% | 73.57% | 85.77% |
| 20-Day Relative Strength | 72.75 | 62.61 | 60.38 | 63.07 | 68.33 |
| Weighted Alpha | +228.20 | +44.13 | +32.05 | +45.02 | +24.65 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 64% Buy | 56% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.87% since 02/13/24 | +6.94% since 02/04/26 | -0.08% since 02/04/26 | -1.10% since 02/04/26 | +5.59% since 02/04/26 |
| Low | 10.09 on 02/16/24 | 186.58 on 02/05/26 | 363.65 on 02/10/26 | 144.62 on 02/11/26 | 58.00 on 02/05/26 |
| High | 10.35 on 02/14/24 | 200.46 on 02/11/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +2.60% since 01/19/24 | +5.89% since 01/09/26 | +12.20% since 01/09/26 | +19.42% since 01/09/26 | +8.92% since 01/09/26 |
| Low | 9.97 on 01/22/24 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 10.44 on 02/09/24 | 200.46 on 02/11/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +109.61% since 11/21/23 | +12.50% since 11/11/25 | +8.11% since 11/11/25 | +18.00% since 11/11/25 | +24.88% since 11/11/25 |
| Low | 3.80 on 11/28/23 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 10.44 on 02/09/24 | 200.46 on 02/11/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +222.33% since 08/21/23 | +35.32% since 08/11/25 | +28.35% since 08/11/25 | +20.05% since 08/11/25 | +32.46% since 08/11/25 |
| Low | 2.10 on 10/04/23 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 10.44 on 02/09/24 | 200.46 on 02/11/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 744,950 | 299,945,568 | 196,357,104 | 182,665,312 | 123,895,928 |
| Shares Outstanding, K | 72,678 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -88,080,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -9,270,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | -0.33 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/13/23 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/11/24 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.57 | 17.20 | 18.52 | 9.88 |